BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22921902)

  • 1. The methionine 196 arginine polymorphism of the TNF receptor 2 gene (TNFRSF1B) is not associated with worse outcomes in heart failure.
    McTiernan CF; Ramani R; Burkhead B; McNamara D
    Cytokine; 2012 Dec; 60(3):838-42. PubMed ID: 22921902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women.
    Xu F; Zhou G; Han S; Yuan W; Chen S; Fu Z; Li D; Zhang H; Li D; Pang D
    PLoS One; 2014; 9(7):e101138. PubMed ID: 25010932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis.
    Chen W; Xu H; Wang X; Gu J; Xiong H; Shi Y
    Int Immunopharmacol; 2015 Sep; 28(1):146-53. PubMed ID: 26071216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.
    Peral B; San Millán JL; Castello R; Moghetti P; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3977-83. PubMed ID: 12161545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the Greek population.
    Vasilopoulos Y; Manolika M; Zafiriou E; Sarafidou T; Bagiatis V; Krüger-Krasagaki S; Tosca A; Patsatsi A; Sotiriadis D; Mamuris Z; Roussaki-Schulze A
    Mol Diagn Ther; 2012 Feb; 16(1):29-34. PubMed ID: 22111980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFα -857 C/T and TNFR2 +587 T/G polymorphisms are associated with cystic fibrosis in Iranian patients.
    Hassanzad M; Farnia P; Ghanavi J; Parvini F; Saif S; Velayati AA
    Eur J Med Genet; 2019 Nov; 62(11):103584. PubMed ID: 30472484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the simultaneous tumor necrosis factor receptor 2, tumor necrosis factor promoter gene polymorphism represent a higher risk for alcoholic liver disease?
    Machado MV; Martins A; Almeida R; Marques-Vidal P; Gonçalves MS; Camilo ME; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):201-5. PubMed ID: 19212208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy.
    Guan X; Liao Z; Ma H; Qian J; Liu Z; Yuan X; Gomez D; Komaki R; Wang LE; Wei Q
    BMC Cancer; 2011 Oct; 11():447. PubMed ID: 21995493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients.
    González-Lara L; Batalla A; Coto E; Gómez J; Eiris N; Santos-Juanes J; Queiro R; Coto-Segura P
    Arch Dermatol Res; 2015 Jul; 307(5):405-12. PubMed ID: 25537528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFRSF1B and TNF Variants Are Associated With Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19.
    Fricke-Galindo I; Buendía-Roldán I; Ruiz A; Palacios Y; Pérez-Rubio G; de Jesus Hernández-Zenteno R; Reyes-Melendres F; Zazueta-Márquez A; Alarcón-Dionet A; Guzmán-Vargas J; Bravo-Gutiérrez OA; Quintero-Puerta T; Gutiérrez-Pérez IA; Nava-Quiroz KJ; Bañuelos-Flores JL; Mejía M; Rojas-Serrano J; Ramos-Martínez E; Guzmán-Guzmán IP; Chávez-Galán L; Falfán-Valencia R
    J Infect Dis; 2022 Sep; 226(5):778-787. PubMed ID: 35294530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
    Kuwahara A; Yamamori M; Fujita M; Okuno T; Tamura T; Kadoyama K; Okamura N; Nakamura T; Sakaeda T
    J Exp Clin Cancer Res; 2010 Jul; 29(1):100. PubMed ID: 20646319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab.
    Medrano LM; Taxonera C; Márquez A; Barreiro-de Acosta M; Gómez-García M; González-Artacho C; Pérez-Calle JL; Bermejo F; Lopez-Sanromán A; Martín Arranz MD; Gisbert JP; Mendoza JL; Martín J; Urcelay E; Núñez C
    Hum Immunol; 2014 Jan; 75(1):71-5. PubMed ID: 24121042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.
    Glossop JR; Dawes PT; Hassell AB; Mattey DL
    J Rheumatol; 2005 Sep; 32(9):1673-8. PubMed ID: 16142859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking, STAT4 and TNFRSF1B polymorphisms, and systemic lupus erythematosus in a Japanese population.
    Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Atsumi T; Kobashi G; Takahashi H;
    J Rheumatol; 2009 Oct; 36(10):2195-203. PubMed ID: 19684152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial.
    Kubota T; McNamara DM; Wang JJ; Trost M; McTiernan CF; Mann DL; Feldman AM
    Circulation; 1998 Jun; 97(25):2499-501. PubMed ID: 9657468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study.
    Canet LM; Filipescu I; Cáliz R; Lupiañez CB; Canhão H; Escudero A; Segura-Catena J; Soto-Pino MJ; Ferrer MA; García A; Romani L; Pérez-Pampin E; González-Utrilla A; López Nevot MA; Collantes E; Fonseca JE; Sainz J
    Pharmacogenet Genomics; 2015 Jul; 25(7):323-33. PubMed ID: 25850964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis.
    Glossop JR; Nixon NB; Dawes PT; Hassell AB; Mattey DL
    J Rheumatol; 2003 Jul; 30(7):1406-9. PubMed ID: 12858434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability in the severity and outcome of community-acquired pneumonia.
    Solé-Violán J; de Castro Fv; García-Laorden MI; Blanquer J; Aspa J; Borderías L; Briones ML; Rajas O; Carrondo IM; Marcos-Ramos JA; Ferrer Agüero JM; Garcia-Saavedra A; Fiuza MD; Caballero-Hidalgo A; Rodriguez-Gallego C
    Respir Med; 2010 Mar; 104(3):440-7. PubMed ID: 19900796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF receptors 1 and 2 exert distinct region-specific effects on striatal and hippocampal grey matter volumes (VBM) in healthy adults.
    Stacey D; Redlich R; Büschel A; Opel N; Grotegerd D; Zaremba D; Dohm K; Bürger C; Meinert SL; Förster K; Repple J; Kaufmann C; Kugel H; Heindel W; Arolt V; Dannlowski U; Baune BT
    Genes Brain Behav; 2017 Mar; 16(3):352-360. PubMed ID: 27528091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polymorphism rs1799964 in TNF-α gene on survival in depressive patients with chronic heart failure.
    Opielak G; Powrózek T; Skwarek-Dziekanowska A; Sobieszek G; Rahnama-Hezavah M; Małecka-Massalska T
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6652-6659. PubMed ID: 34787869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.